XML 21 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
OPERATING ACTIVITIES      
Net income $ 8,764,000 $ 21,781,000 $ 28,691,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Impairment charges / (reversals) 6,347,000 (365,000) 3,101,000
Gain on extinguishment of debt obligations     (1,423,000)
Gain on sales (59,000)   (14,376,000)
Straight-line rents (38,000) (506,000) (761,000)
Provision for doubtful accounts 1,198,000 1,463,000 1,985,000
Depreciation and amortization 40,787,000 38,594,000 38,700,000
Amortization of intangible lease liabilities (2,751,000) (3,125,000) (4,322,000)
Expense relating to share-based compensation, net 2,930,000 3,168,000 3,531,000
Amortization (including accelerated write-off) of deferred financing costs 1,778,000 1,611,000 2,158,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:      
Rents and other receivables (942,000) (1,346,000) (2,989,000)
Prepaid expenses and other (1,418,000) (1,929,000) (2,460,000)
Accounts payable and accrued liabilities 929,000 (210,000) (950,000)
Net cash provided by operating activities 57,525,000 59,136,000 50,885,000
INVESTING ACTIVITIES      
Acquisitions of real estate (31,923,000) (42,991,000) (38,861,000)
Expenditures for real estate improvements (15,484,000) (12,698,000) (16,254,000)
Net proceeds from sales of real estate 96,170,000 5,891,000 102,124,000
Construction escrows and other 2,301,000 1,922,000 2,107,000
Net cash provided by / (used in) investing activities 51,064,000 (47,876,000) 49,116,000
FINANCING ACTIVITIES      
Repayments under revolving credit facility (197,000,000) (186,400,000) (231,500,000)
Advances under revolving credit facility 191,000,000 192,400,000 150,000,000
Advances under term loans 100,000,000 100,000,000 150,000,000
Mortgage borrowing 50,000,000    
Mortgage repayments (218,757,000) (114,828,000) (177,094,000)
Payments of debt financing costs (1,355,000) (2,879,000) (1,312,000)
Noncontrolling interests:      
Purchase of joint venture minority interests share   (11,216,000)  
Distributions of consolidated joint venture minority interests     (960,000)
Distributions to limited partners (71,000) (78,000) (86,000)
Redemptions of OP Units (8,000) (7,000) (437,000)
Common stock sales less issuance expenses, net (142,000) 41,741,000 41,163,000
Preferred stock dividends (14,408,000) (14,408,000) (14,408,000)
Distributions to common shareholders (17,049,000) (17,001,000) (15,841,000)
Net cash used in financing activities (107,790,000) (12,676,000) (100,475,000)
Net increase (decrease) in cash and cash equivalents 799,000 (1,416,000) (474,000)
Cash and cash equivalents at beginning of year 2,083,000 3,499,000 3,973,000
Cash and cash equivalents at end of year $ 2,882,000 $ 2,083,000 $ 3,499,000